Management of hepatocellular carcinoma with portal vein thrombosis

Matthew Quirk, Yun Hwan Kim, Sammy Saab, Edward Wolfgang Lee

Research output: Contribution to journalReview article

44 Citations (Scopus)

Abstract

Management of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) is complex and requires an understanding of multiple therapeutic options. PVT is present in 10%-40% of HCC at the time of diagnosis, and is an adverse prognostic factor. Management options are limited, as transplantation is generally contraindicated, and surgical resection is only rarely performed in select centers. Systemic medical therapy with sorafenib has been shown to modestly prolong survival. Transarterial chemoembolization has been performed in select cases but has shown a high incidence of complications. Emerging data on treatment of PVT with Y-90 radioembolization suggest that this modality is well-tolerated and associated with favorable overall survival. Current society guidelines do not yet specifically recommend radioembolization for patients with PVT, but this may change with the development of newer staging systems and treatment algorithms. In this comprehensive literature review, we present current and available management options with the relative advantages, disadvantages and contraindications of these treatment options with summarized data on overall survival.

Original languageEnglish
Pages (from-to)3462-3471
Number of pages10
JournalWorld Journal of Gastroenterology
Volume21
Issue number12
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Portal Vein
Hepatocellular Carcinoma
Thrombosis
Survival
Therapeutics
Transplantation
Guidelines
Incidence

Keywords

  • Hepatocellular carcinoma
  • Management
  • Portal vein thrombosis
  • Selective internal radiation therapy
  • Yttrium 90

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Management of hepatocellular carcinoma with portal vein thrombosis. / Quirk, Matthew; Kim, Yun Hwan; Saab, Sammy; Lee, Edward Wolfgang.

In: World Journal of Gastroenterology, Vol. 21, No. 12, 01.01.2015, p. 3462-3471.

Research output: Contribution to journalReview article

Quirk, Matthew ; Kim, Yun Hwan ; Saab, Sammy ; Lee, Edward Wolfgang. / Management of hepatocellular carcinoma with portal vein thrombosis. In: World Journal of Gastroenterology. 2015 ; Vol. 21, No. 12. pp. 3462-3471.
@article{d5eb078692334b0fb24331db3cd35192,
title = "Management of hepatocellular carcinoma with portal vein thrombosis",
abstract = "Management of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) is complex and requires an understanding of multiple therapeutic options. PVT is present in 10{\%}-40{\%} of HCC at the time of diagnosis, and is an adverse prognostic factor. Management options are limited, as transplantation is generally contraindicated, and surgical resection is only rarely performed in select centers. Systemic medical therapy with sorafenib has been shown to modestly prolong survival. Transarterial chemoembolization has been performed in select cases but has shown a high incidence of complications. Emerging data on treatment of PVT with Y-90 radioembolization suggest that this modality is well-tolerated and associated with favorable overall survival. Current society guidelines do not yet specifically recommend radioembolization for patients with PVT, but this may change with the development of newer staging systems and treatment algorithms. In this comprehensive literature review, we present current and available management options with the relative advantages, disadvantages and contraindications of these treatment options with summarized data on overall survival.",
keywords = "Hepatocellular carcinoma, Management, Portal vein thrombosis, Selective internal radiation therapy, Yttrium 90",
author = "Matthew Quirk and Kim, {Yun Hwan} and Sammy Saab and Lee, {Edward Wolfgang}",
year = "2015",
month = "1",
day = "1",
doi = "10.3748/wjg.v21.i12.3462",
language = "English",
volume = "21",
pages = "3462--3471",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "12",

}

TY - JOUR

T1 - Management of hepatocellular carcinoma with portal vein thrombosis

AU - Quirk, Matthew

AU - Kim, Yun Hwan

AU - Saab, Sammy

AU - Lee, Edward Wolfgang

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Management of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) is complex and requires an understanding of multiple therapeutic options. PVT is present in 10%-40% of HCC at the time of diagnosis, and is an adverse prognostic factor. Management options are limited, as transplantation is generally contraindicated, and surgical resection is only rarely performed in select centers. Systemic medical therapy with sorafenib has been shown to modestly prolong survival. Transarterial chemoembolization has been performed in select cases but has shown a high incidence of complications. Emerging data on treatment of PVT with Y-90 radioembolization suggest that this modality is well-tolerated and associated with favorable overall survival. Current society guidelines do not yet specifically recommend radioembolization for patients with PVT, but this may change with the development of newer staging systems and treatment algorithms. In this comprehensive literature review, we present current and available management options with the relative advantages, disadvantages and contraindications of these treatment options with summarized data on overall survival.

AB - Management of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) is complex and requires an understanding of multiple therapeutic options. PVT is present in 10%-40% of HCC at the time of diagnosis, and is an adverse prognostic factor. Management options are limited, as transplantation is generally contraindicated, and surgical resection is only rarely performed in select centers. Systemic medical therapy with sorafenib has been shown to modestly prolong survival. Transarterial chemoembolization has been performed in select cases but has shown a high incidence of complications. Emerging data on treatment of PVT with Y-90 radioembolization suggest that this modality is well-tolerated and associated with favorable overall survival. Current society guidelines do not yet specifically recommend radioembolization for patients with PVT, but this may change with the development of newer staging systems and treatment algorithms. In this comprehensive literature review, we present current and available management options with the relative advantages, disadvantages and contraindications of these treatment options with summarized data on overall survival.

KW - Hepatocellular carcinoma

KW - Management

KW - Portal vein thrombosis

KW - Selective internal radiation therapy

KW - Yttrium 90

UR - http://www.scopus.com/inward/record.url?scp=84926341363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926341363&partnerID=8YFLogxK

U2 - 10.3748/wjg.v21.i12.3462

DO - 10.3748/wjg.v21.i12.3462

M3 - Review article

C2 - 25834310

AN - SCOPUS:84926341363

VL - 21

SP - 3462

EP - 3471

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 12

ER -